First AD

Second AD

AHA Guidelines and Patient Mortality

Video content above is prompted by the following:

Please discuss atherosclerotic cardiovascular disease (ASCVD).

Clinical

clinical page is a resource for content on every specialty, disease, and topic available on our medical news site.

Peer Exchange

HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.

Video Series

From LDL-C to Lp(a): A Multispecialty Approach to Reducing the Rising Tide of Cardiovascular Disease

Atherosclerotic cardiovascular disease (ASCVD) is a condition characterized by the buildup of atherosclerotic plaques within arterial walls, leading to narrowed and hardened arteries. This process can result in reduced blood flow and increased risk of cardiovascular events such as heart attacks and strokes. Risk factors include high cholesterol, hypertension, smoking, diabetes, and a sedentary lifestyle. Management involves lifestyle modifications, pharmacotherapy, and sometimes surgical interventions. Early detection and intervention are crucial in preventing the progression of ASCVD and reducing associated morbidity and mortality.

Panelists discuss how effective management of dyslipidemia through adherence to AHA guidelines is crucial for reducing cardiovascular mortality rates and improving patient outcomes.